Literature DB >> 2014975

In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.

P C Fuchs1, S Stickel, P H Anderson, A L Barry, S Shilling.   

Abstract

At clinically achievable levels (e.g., 25 micrograms/ml), sulbactam exerted no effect on aminoglycoside concentrations when incubated together in pooled serum at 37 degrees C for up to 24 h. Sulbactam alone and in combination with ampicillin or cefoperazone inactivated tobramycin, gentamicin, netilmicin, and amikacin in vitro when the sulbactam concentration was 200 to 225 micrograms/ml. At 75 micrograms/ml, sulbactam inactivated only tobramycin. Inactivation of tobramycin by high concentrations of sulbactam occurred even at -20 degrees C, but not at -70 degrees C, and was influenced by the serum matrix.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014975      PMCID: PMC244964          DOI: 10.1128/AAC.35.1.182

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

Authors:  J E McLaughlin; D S Reeves
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

3.  Therapeutic implications of interaction of gentamicin and penicillins.

Authors:  P Noone; J R Pattison
Journal:  Lancet       Date:  1971-09-11       Impact factor: 79.321

4.  Laboratory and clinical conditions for gentamicin inactivation by carbenicillin.

Authors:  L J Riff; G G Jackson
Journal:  Arch Intern Med       Date:  1972-12

5.  Observed differences in amikacin pharmacokinetic parameters and dosage recommendations determined by enzyme immunoassay and fluorescence polarization immunoassay.

Authors:  B E Bleske; T A Larson; J C Rotschafer
Journal:  Ther Drug Monit       Date:  1987       Impact factor: 3.681

6.  Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.

Authors:  M I Thompson; M E Russo; B J Saxon; E Atkin-Thor; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

7.  Comparative study of the ability of four aminoglycoside assay techniques to detect the inactivation of aminoglycosides by beta-lactam antibiotics.

Authors:  M A Pfaller; G G Granich; R Valdes; P R Murray
Journal:  Diagn Microbiol Infect Dis       Date:  1984-04       Impact factor: 2.803

8.  Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.

Authors:  D C Blair; D O Duggan; E T Schroeder
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

9.  In vitro interaction of aminoglycosides with beta-lactam penicillins.

Authors:  S M Wallace; L Y Chan
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

10.  Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions.

Authors:  J A Pieper; R A Vidal; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

View more
  2 in total

1.  Pharmacokinetic parameters of netilmicin and protective effect of piperacillin regarding nephrotoxicity caused by netilmicin.

Authors:  M Santos Navarro; A Zarzuelo Castañeda; F G López; A Sánchez Navarro; M Arévalo; J M Lanao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

2.  Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.

Authors:  J N Walterspiel; S Feldman; R Van; W R Ravis
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.